125 related articles for article (PubMed ID: 23426452)
1. Structured diagnostic and treatment approach versus the usual primary care approach in patients with gastroesophageal reflux disease: a cluster-randomized multicenter study.
Bergquist H; Agréus L; Tillander L; Johnsson F; Sörngård H; Sjöstedt S; Hellström PM
J Clin Gastroenterol; 2013 Aug; 47(7):e65-73. PubMed ID: 23426452
[TBL] [Abstract][Full Text] [Related]
2. Randomised clinical trial: a comparison between a GerdQ-based algorithm and an endoscopy-based approach for the diagnosis and initial treatment of GERD.
Jonasson C; Moum B; Bang C; Andersen KR; Hatlebakk JG
Aliment Pharmacol Ther; 2012 Jun; 35(11):1290-300. PubMed ID: 22510027
[TBL] [Abstract][Full Text] [Related]
3. The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
Moayyedi P; Armstrong D; Hunt RH; Lei Y; Bukoski M; White RJ
Am J Gastroenterol; 2010 Nov; 105(11):2341-6. PubMed ID: 20842110
[TBL] [Abstract][Full Text] [Related]
4. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
Komatsu-Tanaka M; Iwakiri R; Fujimoto K; Fujiwara Y; Inamori M; Tanaka J; Shimatani T; Akiyama J; Ando T; Manabe N; Kinjo F; Deguchi R; Kusano M
Dig Endosc; 2012 Nov; 24(6):407-11. PubMed ID: 23078431
[TBL] [Abstract][Full Text] [Related]
5. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
[TBL] [Abstract][Full Text] [Related]
6. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease.
Jonasson C; Wernersson B; Hoff DA; Hatlebakk JG
Aliment Pharmacol Ther; 2013 Mar; 37(5):564-72. PubMed ID: 23289763
[TBL] [Abstract][Full Text] [Related]
7. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
8. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
Hongo M; Miwa H; Kusano M;
J Gastroenterol Hepatol; 2012 May; 27(5):913-8. PubMed ID: 22142515
[TBL] [Abstract][Full Text] [Related]
9. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
Lacy BE; Chehade R; Crowell MD
Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
[TBL] [Abstract][Full Text] [Related]
10. [GerdQ: tool for the diagnosis and management of gastroesophageal reflux disease in primary care].
Della Casa D; Missale G; Cestari R
Recenti Prog Med; 2010 Mar; 101(3):115-7. PubMed ID: 20461953
[TBL] [Abstract][Full Text] [Related]
11. A comparison between a gastroesophageal reflux disease questionnaire-based algorithm and multichannel intraluminal impedance-pH monitoring for the treatment of gastroesophageal reflux-induced chronic cough.
Li W; Zhang T; Gu W; Shi W; Wang S; Zhu Y; Shi C; Yu L; Xu X
Ther Adv Respir Dis; 2024; 18():17534666231220817. PubMed ID: 38183243
[TBL] [Abstract][Full Text] [Related]
12. Endoluminal gastroplication for the treatment of gastroesophageal reflux disease: a 2-year prospective pilot study from Taiwan.
Liao CC; Lee CL; Lin BR; Bai CH; Hsieh YH; Wu CH; Gostout CJ
J Gastroenterol Hepatol; 2008 Mar; 23(3):398-405. PubMed ID: 18318824
[TBL] [Abstract][Full Text] [Related]
13. Management of gastro-oesophageal reflux disease in primary care: a European observational study.
Gisbert JP; Cooper A; Karagiannis D; Hatlebakk J; Agréus L; Jablonowski H; Tafalla M
Curr Med Res Opin; 2009 Nov; 25(11):2777-84. PubMed ID: 19785512
[TBL] [Abstract][Full Text] [Related]
14. Management of reflux disease in clinical praxis in hungary.
Hritz I; Prónai L; Szalay F; Tulassay Z
Z Gastroenterol; 2005 Jun; 43(6):575-80. PubMed ID: 15986286
[TBL] [Abstract][Full Text] [Related]
15. Development of a refractory gastro-oesophageal reflux score using an administrative claims database.
Gerson LB; Bonafede M; Princic N; Gregory C; Farr A; Balu S
Aliment Pharmacol Ther; 2011 Sep; 34(5):555-67. PubMed ID: 21714794
[TBL] [Abstract][Full Text] [Related]
16. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
Bardhan KD; Berghöfer P
Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
[TBL] [Abstract][Full Text] [Related]
17. Management of gastroesophageal reflux disease in primary care settings in Spain: SYMPATHY I study.
Ferrús JA; Zapardiel J; Sobreviela E;
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1269-78. PubMed ID: 19474743
[TBL] [Abstract][Full Text] [Related]
18. Symptom predictability in gastroesophageal reflux disease and role of proton pump inhibitor test.
Estores DS
Gastroenterol Clin North Am; 2014 Mar; 43(1):27-38. PubMed ID: 24503357
[TBL] [Abstract][Full Text] [Related]
19. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care.
Jones R; Junghard O; Dent J; Vakil N; Halling K; Wernersson B; Lind T
Aliment Pharmacol Ther; 2009 Nov; 30(10):1030-8. PubMed ID: 19737151
[TBL] [Abstract][Full Text] [Related]
20. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
